Lauren Riker

CIK: 0001545439

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (38.5%)

Position reduction

Option Exercises (M)1 (7.7%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)5 (38.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PCRX

Pacira BioSciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

PCRX
Pacira BioSciences, Inc.
Oct 8, 2026
Exercise(M)
Direct
6K shares at avg. $32.35$194K
PCRX
Pacira BioSciences, Inc.
Oct 8, 2026
Sale(S)
Direct
6K shares at avg. $36.32$218K
PCRX
Pacira BioSciences, Inc.
Jun 11, 2026
Sale(S)
Direct
6.1K shares at avg. $23.50$144K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
3.2K shares at avg. $22.32$71K
PCRX
Pacira BioSciences, Inc.
Feb 11, 2026
Award(A)
Direct
19.3K shares-
PCRX
Pacira BioSciences, Inc.
Feb 2, 2026
Sale(S)
Direct
4K shares at avg. $20.81$83K
PCRX
Pacira BioSciences, Inc.
Jan 30, 2026
Tax Payment(F)
Direct
2.8K shares at avg. $20.54$57K
PCRX
Pacira BioSciences, Inc.
Jan 5, 2026
Sale(S)
Direct
1.4K shares at avg. $24.24$34K
PCRX
Pacira BioSciences, Inc.
Jan 2, 2026
Tax Payment(F)
Direct
159 shares at avg. $24.46$4K
PCRX
Pacira BioSciences, Inc.
Jun 4, 2025
Sale(S)
Direct
5.6K shares at avg. $26.21$146K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
3.4K shares at avg. $26.40$89K
PCRX
Pacira BioSciences, Inc.
Feb 1, 2025
Award(A)
Direct
30.6K shares-
PCRX
Pacira BioSciences, Inc.
Jan 2, 2025
Tax Payment(F)
Direct
159 shares at avg. $18.33$3K

		Type	Shares	Price		Ownership
Oct 8, 2026	PCRX Pacira BioSciences, Inc.	Exercise(M)	6,000	$32.35	$194,100	Direct
Oct 8, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	6,000	$36.32	$217,920	Direct
Jun 11, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	6,115	$23.50	$143,703	Direct
Jun 3, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	3,187	$22.32	$71,134	Direct
Feb 11, 2026	PCRX Pacira BioSciences, Inc.	Award(A)	19,273	-	$0	Direct
Feb 2, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	4,000	$20.81	$83,240	Direct
Jan 30, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	2,751	$20.54	$56,506	Direct
Jan 5, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	1,416	$24.24	$34,324	Direct
Jan 2, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	159	$24.46	$3,889	Direct
Jun 4, 2025	PCRX Pacira BioSciences, Inc.	Sale(S)	5,578	$26.21	$146,208	Direct
Jun 3, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	3,374	$26.40	$89,074	Direct
Feb 1, 2025	PCRX Pacira BioSciences, Inc.	Award(A)	30,600	-	-	Direct
Jan 2, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	159	$18.33	$2,914	Direct

1-13 of 13 transactions

About RIKER LAUREN

RIKER LAUREN (SEC CIK 0001545439) files insider reports with the SEC as Senior Vice President, Finance of Pacira BioSciences, Inc. (PCRX).

Signal8 holds 9 ownership filings by RIKER LAUREN, all Form 4s, filed between Jan 6, 2025 and Oct 9, 2026. Those filings report 13 transactions, from Jan 2, 2025 to Oct 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on RIKER LAUREN's filings is in BRISBANE, CA.

Recent filings by RIKER LAUREN

Oct 8, 2026: Option exercise of PCRX shares (Form 4, code M).
Oct 8, 2026: Open-market sale of PCRX shares (Form 4, code S).
Jun 11, 2026: Open-market sale of PCRX shares (Form 4, code S).
Jun 3, 2026: Tax withholding of PCRX shares (Form 4, code F).
Feb 11, 2026: Grant or award of PCRX shares (Form 4, code A).

Other insiders filing for Pacira BioSciences, Inc. (PCRX)

SLONIN JONATHAN, Chief Medical Officer
Hirawat Samit, Director
CHRISTIE CHRISTOPHER, Director
WIGGANS THOMAS G, Director
Young Alethia, Director
YANG MICHAEL J., Director

How to read Form 4 transaction codes